The low frequency of rare mutations in candidate genes among patients with primary severe hypertriglyceridemia suggests that routine genetic testing may not be clinically warranted in this population.
No takes yet. Share an insight, caveat, or question.
May not support routine genetic testing in primary severe hypertriglyceridemia; leaves open polygenic or other etiologies.
Lamíquiz-Moneo et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: